Sign in

Caesars Entertainment, Inc. CZR

Price 29.7 USD
as of 2026-09-04
41/100
Weak
Quality37
Growth40
Balance-sheet strength16
Valuation55
Momentum60
Income50

Composite 41/100; the shares have moved about 29% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Balance-sheet strength ranks 16/100 — a strong mark against it.

Case for

Momentum ranks 60/100 — a slight point in its favour. Valuation ranks 55/100 — a slight point in its favour.

Case against

Balance-sheet strength ranks 16/100 — a strong mark against it. Quality ranks 37/100 — a moderate mark against it. Growth ranks 40/100 — a slight mark against it.

What the company does Caesars Entertainment operates gaming and hospitality properties across 18 states, offering slots, table games, hotels, dining, and online sports wagering in 42 jurisdictions. The company also manages retail and iGaming platforms, including poker and keno, alongside entertainment venues.

Key financials Caesars reports gross margins of 49.9% but net margins of -4.2%, with revenue growth at 2.7% and EPS growth at 41.7%. Leverage is high: Debt/Equity 7.23x and Net debt/EBITDA 7.28x, with interest coverage at 0.81x. ROE is -10.7%, ROA 4.1%, and ROCE 6.4%.

Stock health Momentum is mixed: 12-month +4.00%, 6-month +39.14%, but -4.11% from the 52-week high. RSI(14) is 46.10, indicating neutral momentum. The Sideravia Score is 43.1, with Valuation at 63.9 and Momentum at 65.3.

Price vs fair value The stock trades at a **PREMIUM of 61.90%** to our fair-value estimate of 11.28 and a **discount of 5.59%** to the analyst 12-month target of 31.27. - Q2 results topped revenue estimates despite a reported loss (Zacks, StockStory). - Analysts highlight narrowing losses ahead of the Fertitta acquisition (WSJ). - Recent news flow includes sector updates on hotel launches and app developments (Hotel Dive, The Fly).

Looking forward Forward P/E is 39.37x, reflecting high expectations. The pending Fertitta acquisition may reshape leverage and growth trajectory. Analysts remain cautious on near-term profitability despite revenue beats.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.